Follow The Filings

RYN Rayonier Inc.

Real Estate, filed as RAYONIER INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 2 Owners
  • Max 0.3%
  • $761K
  • 1 reduce

In 2026 Q3 Murphy Pohlad trimmed Rayonier.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 0.26%

Who owns RYN

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.26%, was 0.32% Reduce −6.2% 41,040 $753K History
Kentucky Trust Co., Kentucky Trust <0.01% Hold 411 $8K History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by RYN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RYN insider trades
  • None no insider bought on the open market
  • $409K sold by 3 insiders outside a trading plan
  • $16K sold by 1 insider under 10b5-1 plans
  1. Ryan M. Daniels SVP, Wood Products
    Sale
    $255 14 shares at $18.22 <0.1% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  2. Ryan M. Daniels SVP, Wood Products
    Planned sale
    $16K 887 shares at $18.56 1.6% of stake
    Traded Sep 30 Filed Oct 1
    ↗
  3. Mark R Bridwell EVP, GC and Secretary
    Sale
    $107K 5,318 shares at $20.19 3.9% of stake
    Traded Sep 10 Filed Sep 11
    ↗
  4. Christopher T Corr SVP, Real Estate Development
    Sale
    $301K 14,255 shares at $21.12 20% of stake
    Traded Nov 19, 2025 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 stock grants, 25 share withholdings for taxes, and 2 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K/A 9.01 Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.06B $1.26B $0.483B
Gross profit * $292.95M $476.68M $155.83M
Gross margin * 27.8% 37.8% 32.3%
Net income $173.49M $359.15M $474.38M
Net margin * 16.4% 28.5% 98.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $316.96M $436.89M $883.76M
Total non-current assets * $3.33B $3.04B $2.52B
Total assets $3.65B $3.47B $3.4B
Total current liabilities $140.28M $388.71M $271.28M
Total equity $1.86B $1.77B $2.21B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $298.38M $261.59M $256.66M
Cash from investing $124.09M $354.01M $615.05M
Cash from financing -$328.87M -$479.36M -$372.87M
Net change in cash $92.97M $134.83M $500.24M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.